RecruitingNCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Studying Down syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Duke University
- Principal Investigator
- Chi HornikDuke Clinical Research Institute
- Intervention
- The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:(drug)
- Enrollment
- 5000 enrolled
- Eligibility
- 0-20 years · All sexes
- Timeline
- 2020 – 2027
Study locations (30)
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States
- University of California, Los Angeles Medical Center, Los Angeles, California, United States
- Lucile Packard Children's Hospital, Palo Alto, California, United States
- Colorado University Denver, Aurora, Colorado, United States
- The Children's Hospital Colorado, Aurora, Colorado, United States
- Alfred I. DuPont Hospital for Children, Wilmington, Delaware, United States
- University of Florida Jacksonville Shands Medical Center, Jacksonville, Florida, United States
- Kapiolani Womens and Childrens Medical Center, Honolulu, Hawaii, United States
- Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
- Riley Hospital for Children at Indiana University, Indianapolis, Indiana, United States
- University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States
- University of Kansas Medical Center-JG Kidney Institute, Kansas City, Kansas, United States
- University of Louisville Norton Childrens Hospital, Louisville, Kentucky, United States
- Tulane University Health Science Center, New Orleans, Louisiana, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
The Emmes Company, LLC · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04278404 on ClinicalTrials.govOther trials for Down syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07416201Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without ThymectomyNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNANCT07484464Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down SyndromeRiphah International University
- RECRUITINGNANCT07296861HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down SyndromeUNC Lineberger Comprehensive Cancer Center
- RECRUITINGNCT07195253Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down SyndromeHospices Civils de Lyon
- RECRUITINGNANCT07425769Adapting RDAD for DSUniversity of Kansas Medical Center
- ENROLLING BY INVITATIONNCT07413224Qualitative Effects of AEF0217 in Down Syndrome PeopleAelis Farma
- RECRUITINGPHASE4NCT07280468Endotype DIrected Treatment for OSA in Down SyndromeUniversity of Arizona
- RECRUITINGPHASE2NCT07242638Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down SyndromeIcahn School of Medicine at Mount Sinai